Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
342 participants
INTERVENTIONAL
2021-01-05
2024-12-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specific Aim 1 (Experiment 1): Subaim 1a: Identify child characteristics associated with learning from overhearing. In a prior study, the investigators found that 13 children with ASD were able to learn the meanings of novel words that they heard used in a conversation involving two adults. In the current study, the investigators aim to study a larger sample to identify what child characteristics are associated with good learning in an overhearing situation as compared to a situation in which the child is directly taught the new word. Subaim 1b: Assess retention and generalization of words learned from overhearing. The investigators will re-test children on their knowledge of the word meanings after a 10-minute delay to see if they both retain the word meanings and can generalize the new words to new situations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study 2: Learning New Words From Overhearing in Children With Autism Spectrum Disorder (ASD)
NCT05192109
Word Learning in Children With Autism
NCT03419611
How Simplified Language Affects Comprehension and Learning in Young Autistic Children
NCT05707923
Predicting Language and Literacy Growth in Children With ASD Using Statistical Learning
NCT06332144
Retrieval-Based Word Learning in Autistic Children
NCT06466876
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Addressed
Children participate in an interaction with an experimenter who uses the word to be learned.
Addressed Speech
New words are introduced directly to the child by an experimenter.
Overheard
Children observe while an experimenter uses the word to be learned in an interaction with another experimenter.
Overheard Speech
New words are introduced with the child as an observer rather directly taught.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Overheard Speech
New words are introduced with the child as an observer rather directly taught.
Addressed Speech
New words are introduced directly to the child by an experimenter.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* born premature (\< 36 weeks)
* has uncorrected hearing or vision impairments
* has developmental disorders or medical conditions other than ASD that affect language or cognition (excepting psychiatric conditions often comorbid with ASD such as ADHD)
* has a history of photosensitive epileptic seizures
18 Months
71 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emerson College
OTHER
New York University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emerson College
Boston, Massachusetts, United States
New York University
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
280521
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.